On Monday, Hookipa Pharma Inc (NASDAQ: HOOK) opened lower -3.55% from the last session, before settling in for the closing price of $0.73. Price fluctuations for HOOK have ranged from $0.41 to $2.05 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 26.65% over the past five years. Company’s average yearly earnings per share was noted 58.43% at the time writing. With a float of $70.40 million, this company’s outstanding shares have now reached $96.55 million.
Let’s look at the performance matrix of the company that is accounted for 151 employees.
Hookipa Pharma Inc (HOOK) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Hookipa Pharma Inc is 28.85%, while institutional ownership is 35.34%. The most recent insider transaction that took place on Aug 21 ’23, was worth 5,075. In this transaction Chief Financial Officer of this company bought 7,000 shares at a rate of $0.72, taking the stock ownership to the 43,092 shares. Before that another transaction happened on Aug 16 ’23, when Company’s Chief Financial Officer bought 8,000 for $0.71, making the entire transaction worth $5,712. This insider now owns 36,092 shares in total.
Hookipa Pharma Inc (HOOK) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 58.43% per share during the next fiscal year.
Hookipa Pharma Inc (NASDAQ: HOOK) Trading Performance Indicators
Check out the current performance indicators for Hookipa Pharma Inc (HOOK). In the past quarter, the stock posted a quick ratio of 3.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.91, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.51 in one year’s time.
Technical Analysis of Hookipa Pharma Inc (HOOK)
Hookipa Pharma Inc (NASDAQ: HOOK) saw its 5-day average volume 0.5 million, a negative change from its year-to-date volume of 0.57 million. As of the previous 9 days, the stock’s Stochastic %D was 14.27%. Additionally, its Average True Range was 0.07.
During the past 100 days, Hookipa Pharma Inc’s (HOOK) raw stochastic average was set at 33.79%, which indicates a significant increase from 3.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 72.18% in the past 14 days, which was lower than the 102.98% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7347, while its 200-day Moving Average is $0.6714. Nevertheless, the first resistance level for the watch stands at $0.7380 in the near term. At $0.7690, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.7880. If the price goes on to break the first support level at $0.6880, it is likely to go to the next support level at $0.6690. Assuming the price breaks the second support level, the third support level stands at $0.6380.
Hookipa Pharma Inc (NASDAQ: HOOK) Key Stats
There are currently 98,950K shares outstanding in the company with a market cap of 69.96 million. Presently, the company’s annual sales total 20,130 K according to its annual income of -81,580 K. Last quarter, the company’s sales amounted to 7,410 K and its income totaled -24,820 K.
